AEGLE THERAPEUTICS

In News

The Emerging Role of Exosome Therapeutics in 2026 - bioinformant.com

bioinformant.com - Oct 27, 2025

Aegle Therapeutics Names Scott Braunstein, M.D. as Chairman of the Board - citybiz

citybiz - Jul 15, 2025

Aegle Therapeutics Corp. Announces Positive Data for the First Patient in a Phase 1/2a Clinical Trial Dosed With AGLE-102™, a Novel Extracellular Vesicle Therapy - PR Newswire

PR Newswire - Jan 08, 2024

Clinical Trial Update: First Patient Dosed in Phase 1/2a Trial of AGLE-102 in DEB - The Dermatology Digest

The Dermatology Digest - Aug 14, 2024

Six exosome therapy companies driving development in the field - Labiotech.eu

Labiotech.eu - Nov 14, 2024

Exosome Therapeutics Market Size to Hit USD 4,020.75 Thousand by 2034 - Precedence Research

Precedence Research - Oct 06, 2025

Epidermolysis Bullosa Treatment Pipeline Shows Strong Momentum as 18+ Pharma Companies in the Race | DelveInsight - Barchart.com

Barchart.com - May 29, 2026

Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats - Nature

Nature - Oct 22, 2020

Aegle Therapeutics Prepares Phase 1/2a Trial of BM-MSC Derived Extracellular Vesicles - bioinformant.com

bioinformant.com - Jul 20, 2018

Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight - PR Newswire

PR Newswire - Mar 17, 2026

Funding Flows Freely into Exosome Therapeutics in 2025 - bioinformant.com

bioinformant.com - Jan 04, 2025

Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - PR Newswire

PR Newswire - Nov 04, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment